**Specifications Table**Table**Subject area***Biology***More specific subject area***Biochemistry, Recombinant Proteins, Enzymatic assays and analysis***Type of data***Figure (SDS-PAGE image), graph***How data was acquired***SDS-PAGE, Fluorimetry (Biotek Synergy2 multimode plate reader), Densitometry***Data format***Analyzed***Experimental factors***Purified His*~*6*~*-MBP-VSQNY↓PIVQ-mApple recombinant fusion protein substrate in cleavage buffer (50 mM sodium-acetate, 300 mM NaCl, 0.05% Tween 20, pH 7.0)***Experimental features***Tryptic digestion and binding tests of untreated and treated His*~*6*~*-MBP-VSQNY↓PIVQ-mApple to Ni-NTA magnetic agarose beads***Data source location***not applicable***Data accessibility***Data is with this article.*

**Value of the data**•Data from tryptic digestion may provide useful information on the folding properties of the fluorescent substrates•In the case of homogenous protease assays, solution phase extraction may be used to remove substrates and N-terminal cleavage fragments from reaction mixture, the dependence of binding efficiency on the concentration of the applied magnetic beads and the incubation time need to be optimized for efficient attachment•Exploring the changes in the binding abilities and fluorescent properties of His~6~-MBP-VSQNY↓PIVQ-mApple recombinant protein upon TCA- treatment or heat-denaturation may provide valuable data for the methods used to stop enzyme reactions in the case of a homogenous assay protocol

1. Data {#s0005}
=======

Data presented in this article provide information on characteristics of the His~6~-MBP-VSQNY↓PIVQ-mApple recombinant protein substrate (His~6~, hexahistidine tag; MBP, maltose binding protein; VSQNY↓PIVQ, arrow indicates cleavage position within the sequence of the matrix and capsid cleavage site of human immunodeficiency virus type 1 protease). This recombinant protein have been developed for a high throughput-compatible fluorescent protease assay [@bib1], investigated properties (shown in [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}) of this substrate are important determinants of its usability.Fig. 1Digestion of His~6~-MBP-VSQNY↓PIVQ-mApple substrate by trypsin. The recombinant His~6~-MBP-VSQNY↓PIVQ-mApple substrate was incubated with trypsin up to 60 minutes. Samples were analyzed by SDS-PAGE, and the full-length His~6~-MBP-VSQNY↓PIVQ-mApple substrate and mApple fluorescent protein-containing C-terminal fragments were detected by UV imaging (**A**). The band intensities for mApple were plotted as a function of incubation time (**B**).Fig. 1Fig. 2Dependence of substrate binding to the Ni-NTA coated magnetic beads on bead concentration. The dependence of His~6~-MBP-VSQNY↓PIVQ-mApple recombinant substrate attachment to Ni-NTA coated magnetic beads on bead concentration is shown in the graph. Magnetic bead suspensions were set to different concentrations and were incubated with constant amount of purified substrate. Fluorescence of both supernatant and eluate fractions were measured and plotted against bead concentration. Eluate fractions contain the bead-attached molecules, while supernatant fractions contain the molecules remained in the solution. Fluorescent backgrounds of the supernatant fraction samples are caused by the presence of small amount of free mApple in the substrate solution. Error bars represent SD (n = 2).Fig. 2Fig. 3Dependence of substrate binding to the Ni-NTA coated magnetic beads on incubation time. The dependence of His~6~-MBP-VSQNY↓PIVQ-mApple recombinant substrate attachment to Ni-NTA coated magnetic beads on incubation time is represented. Magnetic bead concentration was set to be constant, while the time of incubation was changed from 0 to 30 minutes. Eluate fractions contain the bead-attached molecules, while supernatant fractions contain the molecules remained in the solution. Supernatant and eluate fractions were analyzed by denaturing SDS-PAGE, and both full-length His~6~-MBP-VSQNY↓PIVQ-mApple substrate (shown by black arrow) and mApple fluorescent protein (white arrow) were detected by UV imaging (**A and B**). Fluorescence of supernatant and eluate fractions were measured and plotted against incubation time (**C**). Fluorescent backgrounds of the supernatant fraction samples are caused by the presence of small amount of free mApple in the substrate solution. Error bars represent SD (n = 2).Fig. 3Fig. 4Effect of trichloroacetic acid (TCA) and heat-denaturation on substrate binding to Ni-NTA coated magnetic beads. To test the possible effects of two methods widely used for stopping enzymatic reactions on recombinant substrate properties, the pre-treatment of the His~6~-MBP-VSQNY↓PIVQ-mApple protein by TCA and by heat was performed. Eluate fractions contain the bead-attached molecules, while supernatant fractions contain the molecules remained in the solution. Relative fluorescence values were expressed as fluorescence relative to that obtained for the untreated substrate. Error bars represent SD (n = 2).Fig. 4

2. Experimental design, materials and methods {#s0010}
=============================================

All materials were purchased from Sigma-Aldrich (St Louis, MO, USA) unless otherwise indicated.

2.1. Substrate digestion by trypsin {#s0015}
-----------------------------------

Digestion of purified His~6~-MBP-VSQNY↓PIVQ-mApple recombinant substrate by trypsin was performed by incubating the reaction mixture in 0.1 M Tris buffer (1 mM CaCl~2~, 0.05% Tween 20, pH 8.0) at 37 °C for different incubation times. Reactions were stopped by the addition of loading buffer (6 × loading buffer, containing 12% SDS and 100 mM β-mercaptoethanol) to reaction mixtures followed by heat-treatment (incubation at 95 °C for 10 min). Separation of the substrates and cleavage products was carried out by denaturing SDS-PAGE using 14% polyacrylamide gel. The electrophoresis was followed by washing the gels with distilled water for 60 min at room temperature to renature the proteins. The fluorescent proteins in the unstained gels were detected by UV imaging using AlphaImager gel documentation system (ProteinSimple). Densitometry of gels was performed by using GelAnalyzer 2010a program (www.gelanalyzer.com).

Preparation of trypsin was performed based on the methods described previously [@bib2], [@bib3], [@bib4].

2.2. Analysis of magnetic bead concentration-dependence of substrate binding {#s0020}
----------------------------------------------------------------------------

His~6~-MBP-VSQNY↓PIVQ-mApple recombinant substrate was incubated with Ni-NTA coated magnetic beads (Qiagen) at 37 °C for 20 min. Magnetic bead suspensions were added to the purified substrate solution in different concentrations, ranging from 0--25% (v/v). Magnetic beads were suspended in cleavage buffer (50 mM sodium acetate, 300 mM NaCl, 0.05% Tween 20, pH 7.0). The final volume of the solutions was set to 70 μl. After incubation the solutions were placed onto DynamagTM-2 magnetic particle concentrator (Thermo Fischer Scientific, Invitrogen) and the supernatants were removed from the beads (supernatant fractions). To prepare eluate fractions the bead-attached molecules were eluted from the beads by incubation in 70 μl elution buffer (100 mM EDTA, 0.05% Tween 20, pH 8.0) for 10 min at room temperature. The fluorescence of both the supernatant and eluate fractions were measured by using Biotek Synergy2 multimode plate reader at 590/35 nm excitation and 645/40 nm emission wavelengths.

2.3. Analysis of time-dependence of substrate binding {#s0025}
-----------------------------------------------------

His~6~-MBP-VSQNY↓PIVQ-mApple recombinant substrate was incubated with Ni-NTA coated magnetic beads (Qiagen) at 37 °C for different times. Concentration of the applied magnetic bead suspension was set to be 5% (v/v), according to the manufacturer\'s protocol. The magnetic beads were suspended in cleavage buffer. After the incubation, the solutions were removed from the beads (supernatant fractions), and to prepare eluate fractions the bead-attached molecules were eluted from the beads by incubation in 70 μl elution buffer for 10 min at room temperature. The fluorescence of both supernatant and eluate fractions were measured by using Biotek Synergy2 multimode plate reader at 590/35 nm excitation and 645/40 nm emission wavelengths, followed by denaturing SDS-PAGE analysis of the samples using 14% polyacrylamide gel. To renature the proteins, after electrophoresis the SDS was washed out by rinsing the gels in distilled water for 60 minutes at room temperature. The fluorescent proteins in the unstained gels were detected by UV imaging using AlphaImager gel documentation system (ProteinSimple).

2.4. Effect of TCA- or heat-treatment on substrate binding {#s0030}
----------------------------------------------------------

The His~6~-MBP-VSQNY↓PIVQ-mApple recombinant substrate was dissolved in cleavage buffer. In the case of TCA treatment, the TCA was added to the substrate solution in 5% (v/v) final concentration, and after centrifugation the precipitate was dissolved in cleavage buffer. In the case of heat-treatment, substrate solution was incubated at 95 °C for 10 min, followed by centrifugation and analysis of the soluble fraction of the sample. Both treatments were followed by incubation of the samples with 5% (v/v) magnetic bead suspension at 37 °C for 20 min, then the solutions were removed from the beads (supernatant fractions), and to prepare eluate fractions the bead-attached molecules were eluted by incubation of the beads in 70 μl elution buffer for 10 min at room temperature. The fluorescence of both supernatant and eluate fractions were measured by using Biotek Synergy2 multimode plate reader at 590/35 nm excitation and 645/40 nm emission wavelengths.
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